Molecular characterization of carbapenem-resistant Acinetobacter baumannii using WGS revealed missed transmission events in Germany from 2012-15

被引:21
作者
Eigenbrod, Tatjana [1 ]
Reuter, Sandra [2 ,3 ]
Gross, Andrea [2 ,3 ]
Kocer, Kaan [1 ,4 ]
Guenther, Frank [1 ,5 ]
Zimmermann, Stefan [1 ]
Heeg, Klaus [1 ]
Mutters, Nico T. [1 ,2 ,3 ]
Nurjadi, Dennis [1 ]
机构
[1] Heidelberg Univ Hosp, Dept Infect Dis Med Microbiol & Hyg, Neuenheimer Feld 324, D-69120 Heidelberg, Germany
[2] Univ Freiburg, Inst Infect Prevent, Med Ctr, Breisacher Str 115B, D-79106 Freiburg, Germany
[3] Hosp Epidemiol, Breisacher Str 115B, D-79106 Freiburg, Germany
[4] Heidelberg Univ Hosp, DZIF, Dept Infect Dis, Neuenheimer Feld 324, D-69120 Heidelberg, Germany
[5] Marburg Univ Hosp, Med Microbiol & Hyg, Hans Meerwein Str 2, D-35043 Marburg, Germany
关键词
EPIDEMIOLOGY; COLONIZATION; MECHANISMS; MORTALITY; CARRIAGE; TOOL;
D O I
10.1093/jac/dkz360
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Infection and colonization with multi-resistant Acinetobacter baumannii causes therapeutic and economic problems in the nosocomial setting. Due to the sensitivity issue of screening schemes for A. baumannii, it is difficult to implement adequate transmission prevention measures. The high discriminatory power of WGS for transmission-chain analysis provides us with the necessary tool to study and identify transmission events. We retrospectively sequenced and analysed 39 A. baumannii isolates from 2012-15 to search for possible missed transmission events. Methods: Molecular typing by WGS was performed for non-repetitive (n=39) carbapenem-resistant A. baumannii. Retrospective assessment of patient records was performed to investigate and confirm possible transmission events. Results: Between July 2012 and September 2015, A. baumannii was isolated from 268 patients, of which 16% (42/268) were carbapenem resistant. Thirty-nine of these isolates were recoverable and sequenced. Fifteen percent (6/39) of these were resistant to all antibiotics tested. Most isolates belong to the circulating IC2 clonal type. SNP analysis revealed four potential outbreak clusters. Two of these clusters showed high concordance with the local spatio-temporal epidemiology, suggesting that transmission events were very likely. Conclusions: Our data suggest that there were two independent transmission events, which would have been missed by conventional MLST owing to high clonality. The routine implementation of WGS can optimize surveillance and initiation of suitable containment measures. In addition, emerging resistance to salvage therapy is a major therapeutic problem and should be monitored closely.
引用
收藏
页码:3473 / 3480
页数:8
相关论文
共 31 条
[1]   Screening for Carbapenem-Resistant Acinetobacter baumannii Colonization Sites: An Implication for Combination of Horizontal and Vertical Approaches [J].
Apisarnthanarak, Anucha ;
Warren, David K. .
CLINICAL INFECTIOUS DISEASES, 2013, 56 (07) :1057-1059
[2]   Insight into Acinetobacter baumannii: pathogenesis, global resistance, mechanisms of resistance, treatment options, and alternative modalities [J].
Asif, Muhammad ;
Alvi, Iqbal Ahmad ;
Rehman, Shafiq Ur .
INFECTION AND DRUG RESISTANCE, 2018, 11 :1249-1260
[3]   Identification of a New Integron Harboring blaIMP-10 in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates [J].
Cayo, Rodrigo ;
Rodrigues-Costa, Fernanda ;
Matos, Adriana P. ;
Carvalhaes, Cecilia G. ;
Jove, Thomas ;
Gales, Ana C. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (06) :3687-3689
[4]   Prevalence of Acinetobacter baumannii carriage in patients of 53 French intensive care units on a given day [J].
Chatellier, D. ;
Burucoa, C. ;
Pinsard, M. ;
Frat, J. -P. ;
Robert, R. .
MEDECINE ET MALADIES INFECTIEUSES, 2007, 37 (02) :112-117
[5]   Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals [J].
Correa, Adriana ;
del Campo, Rosa ;
Escandon-Vargas, Kevin ;
Perenguez, Marcela ;
Rodriguez-Banos, Mercedes ;
Hernandez-Gomez, Cristhian ;
Pallares, Christian ;
Perez, Federico ;
Arias, Cesar A. ;
Canton, Rafael ;
Villegas, Maria V. .
MICROBIAL DRUG RESISTANCE, 2018, 24 (01) :48-54
[6]   Screening for Acinetobacter baumannii Colonization by Use of Sponges [J].
Doi, Yohei ;
Onuoha, Ezenwa O. ;
Adams-Haduch, Jennifer M. ;
Pakstis, Diana L. ;
McGaha, Traci L. ;
Werner, Carly A. ;
Parker, Bridget N. ;
Brooks, Maria M. ;
Shutt, Kathleen A. ;
Pasculle, Anthony W. ;
Muto, Carlene A. ;
Harrison, Lee H. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2011, 49 (01) :154-158
[7]   Spread of NDM-2-producing Acinetobacter baumannii in the Middle East [J].
Espinal, P. ;
Poirel, L. ;
Carmeli, Y. ;
Kaase, M. ;
Pal, T. ;
Nordmann, P. ;
Vila, J. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2013, 68 (08) :1928-1930
[8]   Treatment of Acinetobacter Infections [J].
Fishbain, Joel ;
Peleg, Anton Y. .
CLINICAL INFECTIOUS DISEASES, 2010, 51 (01) :79-84
[9]   Utility of Whole-Genome Sequencing in Characterizing Acinetobacter Epidemiology and Analyzing Hospital Outbreaks [J].
Fitzpatrick, Margaret A. ;
Ozer, Egon A. ;
Hauser, Alan R. .
JOURNAL OF CLINICAL MICROBIOLOGY, 2016, 54 (03) :593-612
[10]   A nosocomial outbreak of Acinetobacter baumannii isolates expressing the carbapenem-hydrolysing oxacillinase OXA-58 [J].
Héritier, C ;
Dubouix, A ;
Poirel, L ;
Marty, N ;
Nordmann, P .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (01) :115-118